Unlock instant, AI-driven research and patent intelligence for your innovation.

Nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patient and application thereof

A nucleic acid aptamer, patient serum technology, applied in the field of biomedical detection and analysis, can solve the problems of insufficient specificity, high production cost, easy to change, etc., and achieves rapid denaturation and renaturation, low production cost, and production cost. high effect

Inactive Publication Date: 2015-07-01
北京莱盟君泰国际医疗技术开发有限公司
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0008] Although the existing technology can also detect ENOX2 protein through ENOX2 recombinant antibody, this technology has many shortcomings and deficiencies: (1) In many cases, regardless of monoclonal antibody, polyclonal antibody or recombinant single-chain antibody, in addition to binding other In addition to specific antigens, it also has binding effects on other proteins, so the specificity is not strong enough; (2) the affinity of recombinant single-chain antibodies is not high; (3) the production process of recombinant single-chain antibodies is complicated, the production cost is high, and in After expression in E. coli, the recombinant antibody must be denatured and refolded
Therefore, different production batches are prone to changes, resulting in changes in the specificity, affinity, and resolution of recombinant antibodies.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patient and application thereof
  • Nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patient and application thereof
  • Nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patient and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0102] 1. Synthesize the peptide chain (the peptide chain was synthesized by Shanghai Qiangyao Biotechnology Co., Ltd.):

[0103] Ac-EEAKEKFKQALSGILIQFE-Amide: (ie

[0104] Ac-GluGluAlaLysGluLysPheLysGlnAlaLeuSerGlyIleLeuIleGlnPheGlu-Amide) (SEQ ID NO.5)

[0105] 2. Synthesis of a DNA library for screening ENOX2 peptide chain aptamers (the DNA library was synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd.):

[0106] Apt-L: 5'-GGT ATT GAG GGT CGC ATC NNN NNN NNN NNN NNN NNN NNN NNNNNN NNN NNN NNN NNN NNN NNN NNN GAT GGC TCT AAC TCT CCT CT (SEQ ID NO. 6), purified by PAGE. Among them, N can be any one of ATGC, a total of 45 N. Therefore, this DNA library should have 445 different nucleotide sequences. From such a large library, aptamers with peptide chain specificity and high affinity to the conserved sequence of ENOX2 were screened out.

[0107] 3. Synthesize three short DNA fragments for PCR primers:

[0108] Apt-F:5'-GGT ATT GAG GGT CGC ATC (SEQ ID NO.8)

[0109] A...

Embodiment 2

[0211] Such as figure 1 As shown, the aptamers SEQ ID NO.1 (Apt-1), SEQ ID NO.2 (Apt-2), SEQ ID NO.3 (Apt -3) and or SEQ ID NO.4 (Apt-4) combined with ENOX2 Western blot; the cDNA of human ENOX2 was cloned into pET-11a expression plasmid, transformed into Escherichia coli, induced by IPGE to express ENOX2 protein, and then extracted for inclusion The total protein in the body, the protein concentration is determined. Take 1 microgram of total inclusion body protein and separate the protein with SDS-PAGE gel according to molecular weight, then transfer the protein to nitrocellulose membrane for WESTERN BLOT analysis. Apt-1, Apt-2, Apt-3 and Apt-4 were labeled with biotin, and the four nucleic acid aptamers labeled with biotin were incubated with nitrocellulose membrane for one hour at room temperature, and after the unbound aptamers were eluted, The membrane was then incubated with streptavidin-alkaline phosphatase, eluted after one hour at room temperature, and the substrate...

Embodiment 3A

[0225] Example 3 Apt-1 inhibits the activity of ENOX2 protein

[0226] The amino acid sequence of human ENOX2 protein is SEQ ID NO.11.

[0227] To determine whether Apt-1 can inhibit the activity of human ENOX2, the present invention uses the effect of the reductase activity of ENOX2 on thioredox protein. To measure thiol production, the turbidity reaction that occurs after mixing insulin and DTT. The result of the present invention shows that after adding the S-tag recombinant human ENOX2 protein, the turbidity is obviously enhanced, indicating that a large amount of thiol is produced. After adding Apt-1 to the reaction, the reductase activity of recombinant human ENOX2 was significantly inhibited. The results are shown in Table 2. It can be seen that Apt-1 can effectively bind human ENOX2 protein, and this specific nucleic acid aptamer can be used to detect ENOX2 protein in serum for early diagnosis of cancer. At the same time, Apt-1 combined with ENOX2 can effectively in...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The embodiment of the invention provides a nucleic acid aptamer capable of detecting an ENOX2 protein in the serum of a cancer patient. The nucleotide sequences of the nucleic acid aptamer are shown in SEQ ID NO. 1, SEQ ID NO. 2, SEQ ID NO. 3 and SEQ ID NO. 4. The nucleic acid aptamer provided by the invention is higher in resolution ratio than that of an antibody, and quite high in specificity; the nucleic acid aptamer screened by an ENOX2 peptide chain only binds the ENOX2 protein and does not bind with other proteins. In addition, the nucleic acid aptamer provided by the invention is quite high in affinity; the dissociation constant of the aptamer screened by taking the protein as a target substance can achieve an nmol / L level, and even pmol / L level; moreover, once the nucleotide sequences of the aptamer are determined, the production cost is quite low, and the nucleic acid aptamer synthesised and produced every time keeps absolutely uniform consistent.

Description

technical field [0001] The invention belongs to the technical field of biomedical detection and analysis, and in particular relates to a nucleic acid aptamer capable of detecting ENOX2 protein in serum of cancer patients and an application thereof. Background technique [0002] Nicotinamide Adenine Dinucleotide Oxidase Disulfide-Thiol Exchanger 2 (Ecto-Nicotinamide Adenine Dinucleotide Oxidase Disulfide-Thiol Exchanger 2 (ENOX2)) is a membrane protein that regulates cell growth and division. During the division and proliferation of malignant tumor cells, ENOX2 protein is expressed in large quantities and cut into the blood, while ENOX2 protein does not exist in the serum of non-cancer patients. In the early stage of cancer, ENOX2 protein appears in serum. Therefore, detection of ENOX2 protein in blood can be used for early diagnosis of cancer. In different tumor cells, ENOX2 mRNA undergoes alternative splicing, resulting in alternatively spliced ​​variant ENOX2. Different...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/115G01N33/574G01N33/573
CPCC12N15/115C40B40/08
Inventor 胡应和李晟
Owner 北京莱盟君泰国际医疗技术开发有限公司